Dr. Mark DiBuono, MD
Claim this profileRichmond Behavioral Associates
Studies Alzheimer's Disease
Studies Agitation
10 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Mark DiBuono, MD is currently running
GSK4527226
for Early Alzheimer's Disease
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (including mild cognitive impairment \[MCI\] and mild dementia due to AD) of 2 dose levels of GSK4527226 compared to placebo.
Recruiting0 awards Phase 214 criteria
ML-004
for Autism Spectrum Disorder
This trial is testing a treatment called ML-004 to see if it can help improve social communication skills in adolescents and adults with Autism Spectrum Disorder (ASD). The study will involve about 150 participants to determine its effectiveness.
Recruiting0 awards Phase 21 criteria
More about Mark DiBuono, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark DiBuono, MD has experience with
- Placebo
- ML-004
- Masupirdine
- Engensis
- ATH-1017
- Simufilam
Breakdown of trials Mark DiBuono, MD has run
Alzheimer's Disease
Alzheimer's Dementia
Pervasive Developmental Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark DiBuono, MD specialize in?
Mark DiBuono, MD focuses on Alzheimer's Disease and Agitation. In particular, much of their work with Alzheimer's Disease has involved APOE ε4 positive patients, or patients who are undergoing treatment.
Is Mark DiBuono, MD currently recruiting for clinical trials?
Yes, Mark DiBuono, MD is currently recruiting for 3 clinical trials in Staten Island New York. If you're interested in participating, you should apply.
Are there any treatments that Mark DiBuono, MD has studied deeply?
Yes, Mark DiBuono, MD has studied treatments such as Placebo, ML-004, Masupirdine.
What is the best way to schedule an appointment with Mark DiBuono, MD?
Apply for one of the trials that Mark DiBuono, MD is conducting.
What is the office address of Mark DiBuono, MD?
The office of Mark DiBuono, MD is located at: Richmond Behavioral Associates, Staten Island, New York 10314 United States. This is the address for their practice at the Richmond Behavioral Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.